Factors influencing over-anticoagulation and bleeding in warfarin therapy during the initial five months of treatment.
Westaway
Kerrie
K
SA Health.
Cruickshank
Mary
M
Roberts
Gregory W
GW
Esterman
Adrian J
AJ
D000359:Aftercare; D000368:Aged; D000704:Analysis of Variance; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects; D016009:Chi-Square Distribution; D015897:Comorbidity; D016903:Drug Monitoring; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology; D006779:Hospitals, Public; D006784:Hospitals, Teaching; D006801:Humans; D008297:Male; D008875:Middle Aged; D010353:Patient Education as Topic; D018579:Patient Selection; D016016:Proportional Hazards Models; D018570:Risk Assessment / Q000458:organization & administration*; D012307:Risk Factors; D013021:South Australia / Q000453:epidemiology; D011795:Surveys and Questionnaires; D013997:Time Factors; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects
D000925:Anticoagulants; D014859:Warfarin